What to Do About Medication After Returning from IVF in Georgia? Protocol Transition and Precautions

Medication transition after returning from IVF in Georgia is a common issue. This article answers core questions about drug consistency, dosage adjustments, blood value monitoring frequency, and how to coordinate with domestic doctors, helping patients safely complete luteal support and follow-up treatment.

What to Do About Medication After Returning from IVF in Georgia? Protocol Transition and Precautions
IVF 2026-07-06

Consultation Record: Day 8 After Transfer, Already Back Home, Unsure How to Continue Medication

A patient returning from Georgia sent a message: "I had my transfer in Tbilisi. Today is day 8, and the medication I brought will only last until day 10. The local doctor prescribed Crinone gel and oral dydrogesterone. After returning home, I visited three hospitals. Some doctors said they don't have this medication, others said I should switch to injections. I don't know what to do now. Would switching directly to injections have any impact?"

This is a typical and practical issue. After completing an IVF cycle in Georgia, patients return with a limited supply of medication. How to transition medication back home involves multiple aspects, including drug availability, differences in administration methods, dosage conversion, and medical coordination. Below, we break down the specific steps based on the nature of the medication protocol.

Direct Answer to the Question: Core Principles of Medication Transition

The overarching principle for medication transition after returning home is: Maintain effective blood concentration and avoid progesterone fluctuations. Luteal support after transfer is crucial for maintaining endometrial receptivity and stabilizing the pregnancy environment. Any change in medication or dosage adjustment should be based on blood value monitoring, not subjective judgment.

  • Priority for Same Ingredient: Prioritize finding drugs with the same generic name as the Georgian prescription. Crinone (progesterone vaginal sustained-release gel) has an identical imported product available domestically. Dydrogesterone (Duphaston) is also a common drug, so there is no issue of shortage.
  • Conversion Required for Different Dosage Forms: If the local area cannot provide the vaginal gel and a switch to injectable or oral progesterone is necessary, an equivalent dose conversion must be performed under a doctor's guidance. Do not simply replace "one unit for one unit."
  • Do Not Stop Medication on Your Own: Even if minor bleeding or abdominal pain occurs, do not stop medication without first confirming progesterone levels. Fluctuations in progesterone levels are common in early pregnancy, and the risk of stopping medication far outweighs the risk of continuing.

The Most Easily Overlooked Detail: Same Drug Name ≠ Same Strength

Some medications used in Georgia come from European or local manufacturers. The same generic drug may have different strengths. For example, progesterone injections are commonly available as 50mg/ml ampoules in Georgia, while 20mg/ml or 10mg/ml ampoules are common domestically. If you convert based on "one ampoule," the actual amount of progesterone absorbed could differ by 2.5 times.

Drug Type Common Strength in Georgia Common Strength Domestically Equivalent Dose Reference
Progesterone Vaginal Gel (Crinone) 90mg/unit 90mg/unit (imported) 1:1 directly replaceable
Dydrogesterone (Duphaston) 10mg/tablet 10mg/tablet 1:1 directly replaceable
Progesterone Injection 50mg/ml ampoule 20mg/ml or 10mg/ml ampoule Convert by milligrams, not by number of ampoules
Micronized Progesterone Capsules (Oral) 100mg/capsule 100mg/capsule or 200mg/capsule Note the difference in strength per capsule

The Biggest Pitfall: Switching Dosage Forms Without Monitoring Blood Levels

Switching from vaginal gel to injectable, or from oral to vaginal administration, involves significant differences in bioavailability. Vaginal administration acts locally on the uterus with lower systemic blood concentrations; injectable administration distributes systemically with less first-pass metabolism in the liver. Adjusting based solely on "feeling" or "how others use it" can easily lead to insufficient or excessive progesterone.

The correct approach is: Within 3-5 days of returning home, visit a local reproductive center or gynecological endocrinology clinic to check progesterone (P), estradiol (E2), and HCG. Based on the blood results, a doctor can decide whether to adjust the protocol. If the progesterone level is above 15-25 ng/ml (reference ranges vary slightly between centers), the current protocol is effective and can be continued. If it is too low, a dose increase or dosage form change may be necessary.

Practical Process: Steps for Medication Transition from Georgia Return to Domestic Care

  1. Preparation Before Departure: Obtain a complete discharge summary, medication protocol, drug names (generic + brand), dosage, administration method, and expected duration of use from your Georgian doctor. It is best to take photos of the prescription and drug packaging for your records.
  2. Carry Sufficient Medication: Bring at least 10-14 days' worth of medication, considering travel time and the transition window after returning home. Purchasing the same drugs domestically may take time, and some are prescription-only, requiring a doctor's prescription.
  3. Schedule an Appointment After Arrival: Prioritize a tertiary hospital with a reproductive medicine or endocrinology department. If no reproductive center is available locally, choose a gynecological endocrinology or family planning department, and explain in advance that it is for "continuation of luteal support after embryo transfer."
  4. Visit with Your Documents: Show the domestic doctor your Georgian medical records and medication protocol. Also inform them of the time of your last dose, transfer date, and current symptoms (any abdominal pain, bleeding, nausea, etc.).
  5. Complete Blood Value Monitoring: Have blood drawn to check HCG, progesterone, and estradiol. Based on the results, the domestic doctor will decide whether to continue the original protocol, adjust the dose, or change the dosage form.

The Doctor's Perspective: Clinical Decision Logic for Medication Adjustment

From a doctor's perspective, adjustments to luteal support after transfer are primarily based on three factors: blood progesterone level, medication adherence, and patient tolerance.

  • Blood Progesterone Level: If the progesterone level is within the target range, even if the dosage form differs from before, a change is usually unnecessary as long as the equivalent dose is consistent. If progesterone is low, first rule out missed doses or poor absorption before considering a dose increase or dosage form change.
  • Medication Adherence: Some patients dislike vaginal gels, or experience hardening or pain at injection sites. In such cases, the doctor will assess whether switching to oral medication or another vaginal preparation is suitable.
  • Patient Tolerance: Oral progesterone can cause dizziness, drowsiness, or liver function fluctuations; injectable progesterone can lead to local sterile abscesses. If significant adverse reactions occur, the doctor will weigh the pros and cons and adjust accordingly.

It is worth noting that domestic doctors tend to prefer domestic or imported micronized progesterone capsules, progesterone injections, and Crinone. Dydrogesterone, as an oral progesterone, is a common choice due to its lower impact on the liver and lack of drowsiness.

Timeline: Medication Monitoring Rhythm After Returning Home

Time Point Recommended Action Purpose
Days 1-3 after return Complete first blood value monitoring (HCG, progesterone, E2) Assess embryo implantation status and luteal support effectiveness
Days 7-10 after return Second blood value monitoring (HCG doubling, progesterone, E2) Confirm pregnancy progress, adjust medication protocol
Days 28-35 after transfer Ultrasound scan (gestational sac, fetal heartbeat) Confirm intrauterine pregnancy and embryo development
Days 70-90 after transfer Gradual dose reduction and discontinuation (under doctor's guidance) Gradually replace luteal function after placenta formation

Frequently Asked Questions

Q: Is the Crinone from Georgia the same as the one bought domestically?
A: Crinone (progesterone vaginal sustained-release gel) is an imported drug. The product used in Georgia is mostly the original brand or from European sources. The product sold domestically is also the original imported brand or an equivalent formulation. The ingredients and bioavailability are essentially the same, so direct replacement is possible.

Q: If I can't find Crinone after returning home, can I use progesterone suppositories instead?
A: Progesterone suppositories have a different release rate compared to the sustained-release gel. Direct substitution is not recommended. If it is truly unavailable, you should switch to injections or oral capsules under a doctor's guidance and monitor blood levels.

Q: On day 10 after transfer, my progesterone is only 12 ng/ml. Do I need to increase the dose?
A: A progesterone level of 12 ng/ml is on the low side. Whether to increase the dose depends on the specific medication protocol, the presence of bleeding or abdominal pain, and the HCG level. It is generally recommended to consult a doctor. A dose increase or dosage form change may be necessary, along with an assessment of embryo viability.

Q: What if my domestic doctor is not familiar with the Georgian protocol?
A: Bring a complete medication record (drug names, dosage, administration method, start time) for the domestic doctor's reference. Most reproductive specialists have a general understanding of luteal support protocols and can make adjustments based on blood results. If the local doctor is unfamiliar, seek a reproductive center with experience in overseas IVF follow-up.

Practitioner's Observation: Three Common Misconceptions About Medication After Overseas IVF

As an overseas coordinator, I have noticed three common problems patients face with medication after returning home:

  • "I feel fine, so I'll reduce the dose": Some patients see good HCG doubling and reduce their progesterone dose on their own, thinking the embryo is stable. In reality, progesterone is essential for maintaining endometrial stability. Reducing it too early can trigger contractions or endometrial shedding, especially before the placenta is fully functional at 12 weeks.
  • "Foreign drugs are better than domestic ones": The drugs used in Georgia are mostly global generic types, and equivalent products are available domestically. There is no evidence that "foreign drugs work better." The key is whether the protocol is suitable for the individual's situation.
  • "Bleeding means it's hopeless": Light brown or pink bleeding in early post-transfer days does not necessarily mean failure. Implantation bleeding, cervical irritation, and hormonal fluctuations can all cause minor bleeding. The key is to check blood values to confirm embryo viability, not to stop medication immediately.

Handling Special Medication Situations

If a patient has other conditions, such as thyroid dysfunction, autoimmune diseases, or coagulation abnormalities, these underlying conditions also need to be managed upon return. Georgian doctors may have used GnRH agonist or antagonist protocols. Some patients may need to continue GnRH agonists for luteal support or endometrial preparation after returning home. These drugs are available domestically but require evaluation and prescription by a specialist.

Additionally, if a patient has undergone PGT-screened embryo transfer or has a history of recurrent implantation failure, they may need to use low molecular weight heparin, aspirin, or immunomodulatory drugs after returning home. These medications should be used under the guidance of a hematology or reproductive immunology department and should not be purchased overseas and brought back independently.

Doctor's Advice: Three Things to Do Before Returning Home

If you are preparing to return from Georgia, or have already returned and are facing medication transition issues, it is recommended to complete the following three steps:

  • Obtain Complete Medical Documents: Discharge summary, medication protocol, embryo information, start and end dates of luteal support. Ask your Georgian doctor to provide a summary in English or Chinese to facilitate quick understanding by domestic doctors.
  • Confirm Domestic Drug Availability: Before departure, check the drug regulatory authority website or hospital pharmacy to see if your medication is available domestically with the same generic name and strength. If not, ask your Georgian doctor for 1-2 alternative protocol suggestions.
  • Contact a Domestic Reproductive Center in Advance: Don't wait until your medication is almost gone to find a hospital. Call two weeks in advance to explain your situation and confirm they are willing to accept overseas IVF referral patients. Some large reproductive centers have dedicated "overseas IVF return follow-up" channels.

Medication transition is a controllable step in the overseas IVF process. With advance planning, complete documentation, and timely monitoring, you can transition smoothly without excessive anxiety.

Comments (0)

Leave a Comment